Abstract
Vector-borne protozoan parasites such as Plasmodium spp. Leishmania spp. and Trypanosoma brucei are responsible for several serious diseases. Significant advances in parasitology have been made using rodent models combined with live imaging techniques, including whole-mouse bioluminescence imaging (BLI). This technique has been applied to investigate parasite dissemination, infectivity, and growth. It has also been used in drug and vaccine testing. This chapter focuses on the methods that utilize whole-mouse BLI to (i) evaluate the homing and infectivity of Plasmodium berghei sporozoites; (ii) conduct in vivo testing of promising chemical entities against Leishmania infantum infection; and (iii) study molecular mechanisms of host susceptibility to Trypanosoma brucei brucei infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO (2020) Fact sheets: vector borne diseases. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases. Accessed 13 Aug 2021
Büscher P, Cecchi G, Jamonneau V et al (2017) Human African trypanosomiasis. Lancet 390:2397–2409
Ashley EA, Pyae Phyo A, Woodrow CJ (2018) Malaria. Lancet 391:1608–1621
Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392:951–970
De Niz M, Spadin F, Marti M et al (2019) Toolbox for in vivo imaging of host-parasite interactions at multiple scales. Trends Parasitol 35:193–212
McLatchie AP, Burrell-Saward H, Myburgh E et al (2013) Highly sensitive in vivo imaging of Trypanosoma brucei expressing “red-shifted” luciferase. PLoS Negl Trop Dis 7:e2571
Tavares J, Costa DM, Teixeira AR et al (2017) In vivo imaging of pathogen homing to the host tissues. Methods 127:37–44
Costa DM, Sá M, Teixeira AR et al (2018) TRSP is dispensable for the Plasmodium pre-erythrocytic phase. Sci Rep 8:15101
Neves JV, Gomes AC, Costa DM et al (2021) A role for hepcidin in the anemia caused by Trypanosoma brucei infection. Haematologica 106:806–818
Graça NA, Gaspar L, Costa DM et al (2016) Activity of bisnaphthalimidopropyl derivatives against Trypanosoma brucei. Antimicrob Agents Chemother 60:2532–2536
Aliprandini E, Tavares J, Panatieri RH et al (2018) Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin. Nat Microbiol 3:1224–1233
Álvarez-Velilla R, Gutiérrez-Corbo MDC, Punzón C et al (2019) A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery. PLoS Negl Trop Dis 13:e0007133
Costa DM, Cecílio P, Santarém N et al (2019) Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery. Sci Rep 9:18989
Ong HB, Clare S, Roberts AJ et al (2020) Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening. Sci Rep 10:4689
Ménard R, Tavares J, Cockburn I et al (2013) Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol 11:701–712
Braks J, Aime E, Spaccapelo R et al (2013) Bioluminescence imaging of P. berghei schizont sequestration in rodents. Methods Mol Biol 923:353–368
Buffet PA, Sulahian A, Garin YJ et al (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39:2167–2168
Nicolas L, Prina E, Lang T et al (2002) Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 40:1666–1669
Cunha J, Carrillo E, Sánchez C et al (2013) Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV− patients in the murine model of visceral leishmaniasis. Parasit Vectors 6:122
Michel G, Ferrua B, Lang T et al (2011) Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro. PLoS Negl Trop Dis 5:e1323
Reimão JQ, Oliveira JC, Trinconi CT et al (2015) Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS Negl Trop Dis 9:e0003556
Melo GD, Goyard S, Lecoeur H et al (2017) New insights into experimental visceral leishmaniasis: real-time in vivo imaging of Leishmania donovani virulence. PLoS Negl Trop Dis 11:e0005924
Khare S, Nagle AS, Biggart A et al (2016) Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537:229–233
Ritchie R, Barrett MP, Mottram JC et al (2020) In vivo bioluminescence imaging to assess compound efficacy against Trypanosoma brucei. In: Michels PAM, Ginger ML, Zilberstein D (eds) Trypanosomatids: methods and protocols, 1st edn. Humana Press, New York, pp 801–817
Franke-Fayard B, Djokovic D, Dooren MW et al (2008) Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites. Int J Parasitol 38:1651–1662
Sereno D, Roy G, Lemesre JL et al (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45:1168–1173
Sacks DL, Melby PC (2015) Animal models for the analysis of immune responses to leishmaniasis. Curr Protoc Immunol 108:19.2.1–19.2.24
Acknowledgments
We apologize to many researchers in this field whose work we have not been able to cite directly because of the limits of space. This work was supported by funds from the Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência (MEC) co-funded by the European Regional Development Fund (FEDER) under the Partnership agreement PT2020, through the Research Unit No. 4293, and the grant PTDC/SAU-PAR/31340/2017.
JT is an Investigator funded by national funds through FCT and co-funded through FEDER Grant CEECIND/02362/2017. DMC and MS are funded by the FCT individual fellowships SFRH/ BD/123734/2016 and SFRH/BD/133485/2017, respectively.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sá, M., Costa, D.M., Tavares, J. (2022). Imaging Infection by Vector-Borne Protozoan Parasites Using Whole-Mouse Bioluminescence. In: Kim, SB. (eds) Bioluminescence. Methods in Molecular Biology, vol 2524. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2453-1_29
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2453-1_29
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2452-4
Online ISBN: 978-1-0716-2453-1
eBook Packages: Springer Protocols